wr 1065 has been researched along with Genome Instability in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baulch, JE; Coleman, MC; Dziegielewski, J; Goetz, W; Grdina, DJ; Morgan, WF; Murley, JS; Spitz, DR | 1 |
Baulch, JE; Dziegielewski, J; Goetz, W; Grdina, DJ; Morgan, WF; Murley, JS | 1 |
Grdina, DJ; Li, JJ; Mauceri, HJ; Miller, RC; Murley, JS; Sutton, HG; Thirman, MJ; Weichselbaum, RR; Woloschak, GE | 1 |
3 other study(ies) available for wr 1065 and Genome Instability
Article | Year |
---|---|
WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability.
Topics: Amifostine; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Genomic Instability; Green Fluorescent Proteins; Humans; Mercaptoethylamines; Micronucleus Tests; Radiation Tolerance; Radiation-Protective Agents; Superoxide Dismutase; X-Rays | 2008 |
Amifostine metabolite WR-1065 disrupts homologous recombination in mammalian cells.
Topics: Amifostine; Animals; Camptothecin; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; DNA-Binding Proteins; Genomic Instability; Humans; Hydroxyurea; Mercaptoethylamines; Rad51 Recombinase; Radiation-Protective Agents; Reactive Oxygen Species; Recombination, Genetic; RNA Interference | 2010 |
A manganese superoxide dismutase (SOD2)-mediated adaptive response.
Topics: Adaptation, Physiological; Alkylating Agents; Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Radiation; Ethylnitrosourea; Female; Genomic Instability; Humans; Mercaptoethylamines; Mice; Mice, Inbred C57BL; Pregnancy; Signal Transduction; Superoxide Dismutase | 2013 |